| Name | Namilumab |
|---|
| Description | Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis[1]. |
|---|---|
| Related Catalog | |
| Target |
GM-CSF[1] |
| In Vivo | Namilumab can be used for the research of rheumatoid arthritis with good tolerance[1]. |
| References |
| No Any Chemical & Physical Properties |